|
Volumn 434, Issue 1-2, 2002, Pages 35-42
|
Glibenclamide attenuates ischemia-induced acidosis and loss of cardiac function in rats
|
Author keywords
31Phosphorus magnetic resonance spectroscopy; Diabetes; Glibenclamide; Heart; Ischemia; Isolated, working; KATP channel; Metabolism; Type 2
|
Indexed keywords
ADENOSINE TRIPHOSPHATE;
CREATINE PHOSPHATE;
GLIBENCLAMIDE;
PHOSPHORUS;
POTASSIUM CHANNEL;
ACIDOSIS;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
CELL LEVEL;
CELL PH;
CLINICAL PROTOCOL;
CONTROLLED STUDY;
CONVALESCENCE;
CORONARY ARTERY BLOOD FLOW;
DRUG MECHANISM;
ERYTHROCYTE;
GLYCOLYSIS;
HEART FUNCTION;
HEART MUSCLE ISCHEMIA;
HEART MUSCLE REPERFUSION;
HEART PROTECTION;
HEART WORK;
MALE;
NONHUMAN;
NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;
PRIORITY JOURNAL;
RAT;
ACIDOSIS;
ADENOSINE TRIPHOSPHATE;
ANIMALS;
CORONARY CIRCULATION;
GLYBURIDE;
GLYCOLYSIS;
HYDROGEN-ION CONCENTRATION;
MALE;
MYOCARDIAL ISCHEMIA;
MYOCARDIUM;
OXIDATIVE PHOSPHORYLATION;
POTASSIUM CHANNELS;
RATS;
RATS, WISTAR;
|
EID: 0037005744
PISSN: 00142999
EISSN: None
Source Type: Journal
DOI: 10.1016/S0014-2999(01)01483-2 Document Type: Article |
Times cited : (3)
|
References (35)
|